Lifeward (LFWD) Cash & Equivalents (2014 - 2026)

Lifeward has disclosed Cash & Equivalents across 13 years of filings, most recently posting $9.4 million for Q2 2026.

• In Q2 2026, Cash & Equivalents rose 83.85% year-over-year to $9.4 million; the TTM figure through Jun 2026 stood at $9.4 million (up 83.85% YoY), while the FY2025 annual figure was $2.2 million, down 67.85% from the prior year.
• Cash & Equivalents came in at $9.4 million for Q2 2026 at Lifeward, down from $11.4 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $82.6 million in Q1 2022 to a low of $2.0 million in Q3 2025.
• Average Cash & Equivalents over 5 years is $31.9 million, with a median of $17.9 million recorded in 2024.
• Year-over-year, Cash & Equivalents sank 81.31% in 2025 and surged 99.41% in 2026.
• Over 5 years, Cash & Equivalents stood at $67.9 million in 2022, then plunged by 58.64% to $28.1 million in 2023, then slumped by 75.98% to $6.7 million in 2024, then sank by 67.85% to $2.2 million in 2025, then soared by 335.59% to $9.4 million in 2026.
• Per Business Quant data, the three most recent Cash & Equivalents figures were $9.4 million in Q2 2026, $11.4 million in Q1 2026, and $2.2 million in Q4 2025.